In an ambitious move to drive cancer research forward, UNMC leadership alongside several community groups testified before the Nebraska Legislature’s Health and Human Services Committee to underscore the critical need for timely access to state cancer data. Dr. Joann Sweasy, director of the Fred &
Doctors have embarked on a groundbreaking study to understand why a unique group of cancer patients, known as "super-survivors," manage to live far longer than expected after being diagnosed with particularly aggressive cancers. This major investigation involves not only eight NHS cancer
Growth hormone-releasing hormone (GHRH), also known as somatoliberin, has emerged as a significant focus in medical research due to its extensive biological activities and therapeutic potential. GHRH, a family of hypothalamic peptide hormones, plays a crucial role in stimulating and modulating the
The development of synthetic intramembrane proteolysis receptors (SNIPRs) engineered by researchers in the United States could be a game-changer for CAR T-cell cancer therapies. This groundbreaking advancement introduces a novel methodology to enhance the precision and safety of CAR T-cell
Triple-negative breast cancer (TNBC) is known for its aggressive nature and limited treatment options. However, a recent breakthrough in personalized immunotherapy offers new hope for patients. Researchers have developed a neoantigen DNA vaccine platform that has shown promising results in
The U.S. Department of Energy's Argonne National Laboratory has been awarded two substantial grants totaling up to $21.7 million from the Advanced Research Projects Agency for Health (ARPA-H), a branch of the Department of Health and Human Services. These significant funds are poised to
